Author(s):
Alameen R, Amirtha R, Anand S, N. Santhi, S.S. Rajendran
Email(s):
rajendran@rvsgroup.com
DOI:
10.52711/2231-5675.2024.00039 
Address:
Alameen R, Amirtha R, Anand S, N. Santhi, S.S. Rajendran*
Department of Pharmaceutical Chemistry, RVS College of Pharmaceutical Sciences, Sulur, Coimbatore, Tamilnadu, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2024
ABSTRACT:
A Simple, sensitive, precise, rapid and economical UV Spectrophotometric method for determining Teneligliptin Hydrobromide Hydrate (THH) in both bulk and various marketed tablet dosage forms was developed and validated. The standard solutions of Teneligliptin Hydrobromide Hydrate (THH) were prepared using Distilled water. The standard solution of THH showed maximum absorption (? max) at wavelength 244nm. This method obeys Beer’s law in the concentration range from 10-50µg/ml. The regression of the curve was found Y=0.00182x+0.0096 and the correlation coefficient was found to be 0.9994. The developed method was applied to marketed brand and generic tablet dosage forms and the % amount of drug estimated was 101.33% and 102% respectively. It was in accordance with the label claim. The Accuracy was found to be 97.7%. The limit of detection and limit of quantification was found to be 0.5439µg/ml and 1.648µg/ml respectively. Precision studies were performed as intraday and interday variations %RSD value within the limit of = 2. The ICH guidelines were followed in the development and validation of the method. This method was simple, rapid and economical for the routine analysis of Teneligliptin Hydrobromide Hydrate (THH) in bulk and pharmaceutical dosage forms.
Cite this article:
Alameen R, Amirtha R, Anand S, N. Santhi, S.S. Rajendran. UV Spectrophotometric Method Development and Validation of Teneligliptin Hydrobromide Hydrate in Bulk and Marketed Brand and Generic Tablet Dosage Form. Asian Journal of Pharmaceutical Analysis. 2024; 14(4):217-1. doi: 10.52711/2231-5675.2024.00039
Cite(Electronic):
Alameen R, Amirtha R, Anand S, N. Santhi, S.S. Rajendran. UV Spectrophotometric Method Development and Validation of Teneligliptin Hydrobromide Hydrate in Bulk and Marketed Brand and Generic Tablet Dosage Form. Asian Journal of Pharmaceutical Analysis. 2024; 14(4):217-1. doi: 10.52711/2231-5675.2024.00039 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2024-14-4-3
REFERENCES:
1. Annapurna MM, Naik RR, Pratyusha SM. Simultaneous spectrophotometric determination of compounds: Application to an anti-diabetic formulation of Teneligliptin and Metformin. Research Journal of Pharmacy and Technology. 2020; 13(4): 1938-42.
2. Kishimoto M. Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes. Diabetes, metabolic syndrome and obesity: targets and Therapy. 2013 May 6:187-95.
3. Saini K, Sharma S, Khan Y. DPP-4 inhibitors for treating T2DM-hype or hope? an analysis based on the current literature. Frontiers in Molecular Biosciences. 2023 May 23; 10:1130625.
4. Varghese L, Murthi K, Pandey K. Teneligliptin as an add on Therapy to Oral Anti diabetic agents in type 2 Diabetes Mellitus. Research Journal of Pharmacy and Technology. 2020; 13(5): 2310-4.
5. Vashi Dhara, Gamit Dharmistha. Development and validation of UV-spectroscopic method for simultaneous estimation of remogliflozin etabonate and teneligliptin in bulk and pharmaceutical dosage form by simultaneous equation method. World Journal of Pharmaceutical. 2022; 8(8): 149-153.
6. PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 53297474, Teneligliptin hydrobromide hydrate; [cited 2023Dec. 12].
7. Shinde VC, Aher KB, Bhavar GB, Kakad SJ, Chaudhari SR. Development and validation of UV spectrophotometric method and high-performance thin layer chromatographic (HPTLC) method for estimation of teneligliptin hydrobromide in pharmaceutical preparation. Der Pharmacia Lettre. 2016; 8(8): 291-301.
8. Gaikwad AS, Raut SR, Bargaje GS. Development and Validation of RP-HPLC and UV-Spectrophotometric Method for Simultaneous Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Pharmaceutical dosage form.
9. Biswas B, Kumar M, Sharma JB, Saini V, Bhatt S. Method Development and Validation for Estimation of Teneligliptin in Tablet Dosage Form by RP-HPLC. Research Journal of Pharmacy and Technology. 2020; 13(4): 1774-8.
10. Bichala PK, Kumar KJ, Suthakaran R, Shankar C. Development and Validation of an Analytical Method for the Estimation of Metformin and Teneligliptin in its Bulk and Tablet Dosage Form by using RP-HPLC. Asian Journal of Pharmaceutical Analysis. 2020; 10(1): 11-4.
11. Mehul M. Patel, Divya Patel, Umang Shah, Heta M. Kachhiya. A Simple, Precise, and Sensitive RP-HPLC Method for Quantification of Teneligliptin Hydrobromide and Metformin Hydrochloride: Development and Validation. Research Journal of Pharmacy and Technology. 2023; 16(2): 495-1
12. Maruthi R, Chandan RS, Barath M, Datta GN, D'silva M, Kumari MK, Ahmad F, Geetha R. Analytical method development and validation of teneligliptin by RP-UFLC. Research Journal of Pharmacy and Technology. 2020; 13(9) :4035-40.
13. Maruthi R, Chandan RS, Barath M, Datta GN, D'silva M, Kumari KM, Ahmad F, Geetha R. Analytical method development and validation of teneligliptin by UV spectroscopy. Research Journal of Pharmacy and Technology. 2021; 14(1): 75-8.
14. Farkade K, Tawar M. Analytical Method Validation and Quantitative Analysis for Active Pharmaceutical Ingredient and Marketed Formulation of Teneligliptin Hydrobromide by UV Spectroscopy. Asian Journal of Pharmaceutical Analysis. 2021; 11(3): 195-8.
15. Pritam S Jain, Prafulla M Patil, Savita J Sonawane, Sanjay J Surana. UV-AUC Spectrophotometric Method for Quantitative Estimation of Teneligliptin. Acta Scientific Pharmaceutical Sciences. 2019; 3(6): 43-47.
16. Pathade PA, Bairagi VA, Ahire YS, Aher BO. Development and validation of stability indicating UV spectrophotometric method for estimation of teneligliptine in bulk and tablet dosage form. Asian Journal of Pharmaceutical Analysis. 2019; 9(3): 128-32.
17. Annapurna MM, Pratyusha SM, Naik RR. New validated spectrophotometric methods for the combined dosage form of Teneligliptin and Metformin. Research Journal of Pharmacy and Technology. 2020; 13(1): 270-4.
18. Kshirsagar, S. and Mane, S. &Hanchate, Y. &Katte, Samartha& Kulkarni, K. UV Spectrophotometric Method Development and Validation for Determination of Teneligliptin Hydrobromide Hydrate in API and in Pharmaceutical Dosage Form. International Journal for Pharmaceutical Research Scholars. 2018; 7: 19-27. 10.31638/IJPRS.V7. I1.00008.
19. ICH I. Q2 (R1): Validation of analytical procedures: text and methodology. InInternational Conference on Harmonization, Geneva. 2005 Nov (PP. 1-13).